Organic & Biomolecular Chemistry
Paper
hands, non-sulfated molecules 9, 13 and 15 did not show any
interaction with TLR4. Only the partially acetylated 10 showed
a slight response at a high concentration (100 μM). Compound
11, bearing both acetate and sulfate esters, induced a TLR4
response at 30 μM. Unexpectedly, the trisulfated (and non-
acetylated) disaccharide 12 (obtained from 11) seemed inac-
tive. Monosulfated compound 14 showed a very low response,
and no significant difference was observed when compared
with the non-substituted analog 15. The highest response was
shown by compound 16, the 3,6,6′-trisulfated disaccharide.
Clearly, these findings indicate that sulfate groups on the
primary positions favored the interaction with TLR4, thus trig-
gering inflammatory signalization. It is difficult however to
explain the absence of activity of the trisulfated molecule 12
because the 6,6′-disulfation pattern of 16 is also present.
Further investigations and other synthetic derivatives may help
explain this result and the role of the specific position of
sulfate groups for TLR4 binding. Anyway, our results on TLR4
binding make compound 16 a promising starting point for the
regulation of inflammatory response.
2 T. Vasselon and P. A. Detmers, Toll receptors: a central
element in innate immune responses, Infect. Immun., 2002,
70, 1033.
3 D. M. Underhill and A. Ozinsky, Toll-like receptors: key
mediators of microbe detection, Curr. Opin. Immunol.,
2002, 14, 103.
4 M. Dajon, K. Iribarren and I. Cremer, Toll-like receptor
stimulation in cancer: A pro- and anti-tumor double-edged
sword, Immunobiology, 2017, 222, 89.
5 K. R. Michels, N. W. Lukacs and W. Fonseca, TLR
Activation and Allergic Disease: Early Life Microbiome and
Treatment, Curr. Allergy Asthma Rep., 2018, 18, 61.
6 S. Mukherjee, S. Karmakar and S. P. Babu, TLR2 and
TLR4 mediated host immune responses in major infectious
diseases: a review, Braz. J. Infect. Dis., 2016, 20, 193.
7 M. K. C. Brunialti, P. S. Martins, H. Barbosa de Carvalho,
F. R. Machado, L. M. Barbosa and R. Salomao, Shock, 2006,
25, 351.
8 E. Gülden and L. Wen, Toll-like receptor activation in
immunity vs. tolerance in autoimmune diabetes, Front.
Immunol., 2014, 5, 119.
9 S. Gupta, A. Maratha, J. Siednienko, A. Natarajan,
T. Gajanayake, S. Hoashi and S. Miggin, Analysis of inflam-
matory cytokine and TLR expression levels in Type 2
Diabetes with complications, Sci. Rep., 2017, 7, 7633.
Conclusions
Altogether, we showed in this current work the potential of
small oligosaccharides to modulate TLR4 activity, and we con- 10 S. Lehnardt, Innate immunity and neuroinflammation in
firmed the need for sulfation and the key role of the 6-sulfate
groups to trigger TLR4 signalization.
the CNS: the role of microglia in Toll-like receptor-
mediated neuronal injury, Glia, 2010, 58, 253.
11 J. Ausseil, N. Desmaris, S. Bigou, R. Attali, S. Corbineau,
S. Vitry, M. Parent, D. Cheillan, M. Fuller, I. Maire,
M.-T. Vanier and J.-M. Heard, Early Neurodegeneration
Progresses Independently of Microglial Activation by
Heparan Sulfate in the Brain of Mucopolysaccharidosis IIIB
Mice, PLoS One, 2008, 3, e2296.
Author contributions
S. T. and J. K. designed and supervised the synthetic
work. R. N. performed the synthesis and the characterization
of the compounds. F. A. designed the biological test performed 12 F. Peri and V. Calabrese, Toll-like Receptor 4 (TLR4)
by A. D. S. T., J. K. and F. A. wrote the paper and together with
J. A. revised its final version.
Modulation by Synthetic and Natural Compounds: An
Update, J. Med. Chem., 2014, 57, 3612.
13 J. Li, A. Csakai, J. Jin, F. Zhang and H. Yin, Therapeutic
Developments Targeting Toll-like Receptor-4-Mediated
Neuroinflammation, ChemMedChem, 2016, 11, 154.
14 M. Molteni, A. Bosi and C. Rossetti, Natural Products with
Conflicts of interest
The authors declare no conflicts of interest.
Toll-Like
Receptor
4
Antagonist
Activity,
Int. J. Inflammation, 2018, 2859135.
15 F. A. Facchini, L. Zaffaroni, A. Minotti, S. Rapisarda,
V. Calabrese, M. Forcella, P. Fusi, C. Airoldi, C. Ciaramelli,
J.-M. Billod, A. B. Schromm, H. Braun, C. Palmer,
R. Beyaert, F. Lapenta, R. Jerala, G. Pirianov, S. Martin-
Santamaria and F. Peri, Structure–Activity Relationship in
Acknowledgements
The authors thank the Conseil Régional de Hauts-de-France
(grant SOLIDE) for financial support and a PhD fellowship for
R. N.
Monosaccharide-Based Toll-Like Receptor
4
(TLR4)
Antagonists, J. Med. Chem., 2018, 61, 2895.
16 Y. Wang, S. Zhang, H. Li, H. Wang, T. Zhang,
M. R. Hutchinson, H. Yin and X. Wang, Small-Molecule
Modulators of Toll-like Receptors, Acc. Chem. Res., 2020,
53, 1046.
Notes and references
1 R. L. Modlin, H. D. Brightbill and P. J. Godowski, The Toll
of Innate Immunity on Microbial Pathogens, N. 17 V. H. Pomin, Sulfated glycans in inflammation, Eur. J. Med.
Engl. J. Med., 1999, 340, 1834.
Chem., 2015, 92, 353.
This journal is © The Royal Society of Chemistry 2021
Org. Biomol. Chem.